Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
In a report released today, James Gordon from J.P. Morgan reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report). The company’s shares opened today at p2,154.00. See what ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback